These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 29343258

  • 1. Mass-spectrometric profiling of cerebrospinal fluid reveals metabolite biomarkers for CNS involvement in varicella zoster virus reactivation.
    Kuhn M, Sühs KW, Akmatov MK, Klawonn F, Wang J, Skripuletz T, Kaever V, Stangel M, Pessler F.
    J Neuroinflammation; 2018 Jan 17; 15(1):20. PubMed ID: 29343258
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis.
    de Araujo LS, Pessler K, Sühs KW, Novoselova N, Klawonn F, Kuhn M, Kaever V, Müller-Vahl K, Trebst C, Skripuletz T, Stangel M, Pessler F.
    J Transl Med; 2020 Jan 07; 18(1):9. PubMed ID: 31910875
    [Abstract] [Full Text] [Related]

  • 4. The association of Varicella zoster virus reactivation with Bell's palsy in children.
    Abdel-Aziz M, Azab NA, Khalifa B, Rashed M, Naguib N.
    Int J Pediatr Otorhinolaryngol; 2015 Mar 07; 79(3):328-31. PubMed ID: 25599860
    [Abstract] [Full Text] [Related]

  • 5. Identification of Cerebrospinal Fluid Metabolites as Biomarkers for Enterovirus Meningitis.
    Ratuszny D, Sühs KW, Novoselova N, Kuhn M, Kaever V, Skripuletz T, Pessler F, Stangel M.
    Int J Mol Sci; 2019 Jan 15; 20(2):. PubMed ID: 30650575
    [Abstract] [Full Text] [Related]

  • 6. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.
    Gregoire SM, van Pesch V, Goffette S, Peeters A, Sindic CJ.
    J Neurol Neurosurg Psychiatry; 2006 Aug 15; 77(8):938-42. PubMed ID: 16844949
    [Abstract] [Full Text] [Related]

  • 7. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels.
    Persson A, Bergström T, Lindh M, Namvar L, Studahl M.
    J Clin Virol; 2009 Nov 15; 46(3):249-53. PubMed ID: 19709927
    [Abstract] [Full Text] [Related]

  • 8. Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens.
    Neu F, Nay S, Schuchardt S, Klawonn F, Skripuletz T, Suehs KW, Pessler F.
    J Transl Med; 2024 Jul 03; 22(1):620. PubMed ID: 38961383
    [Abstract] [Full Text] [Related]

  • 9. Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study.
    Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E.
    Int J Infect Dis; 2013 Jul 03; 17(7):e529-34. PubMed ID: 23566589
    [Abstract] [Full Text] [Related]

  • 10. Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
    Tyrberg T, Nilsson S, Blennow K, Zetterberg H, Grahn A.
    J Neurovirol; 2020 Oct 03; 26(5):719-726. PubMed ID: 32816287
    [Abstract] [Full Text] [Related]

  • 11. Varicella-zoster virus (VZV) DNA in serum of patients with VZV central nervous system infections.
    Grahn A, Bergström T, Runesson J, Studahl M.
    J Infect; 2016 Sep 03; 73(3):254-60. PubMed ID: 27317379
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Varicella zoster virus infections in neurological patients: a clinical study.
    Skripuletz T, Pars K, Schulte A, Schwenkenbecher P, Yildiz Ö, Ganzenmueller T, Kuhn M, Spreer A, Wurster U, Pul R, Stangel M, Sühs KW, Trebst C.
    BMC Infect Dis; 2018 May 25; 18(1):238. PubMed ID: 29801466
    [Abstract] [Full Text] [Related]

  • 14. Varicella-Zoster Virus Meningitis and Encephalitis: An Understated Cause of Central Nervous System Infections.
    Alvarez JC, Alvarez J, Tinoco J, Mellado P, Miranda H, Ferrés M, Forero J, Álvarez C.
    Cureus; 2020 Nov 20; 12(11):e11583. PubMed ID: 33364107
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation.
    Baird NL, Zhu S, Pearce CM, Viejo-Borbolla A.
    Viruses; 2019 Jan 26; 11(2):. PubMed ID: 30691086
    [Abstract] [Full Text] [Related]

  • 17. Subclinical reactivation of varicella zoster virus in all stages of HIV infection.
    Birlea M, Arendt G, Orhan E, Schmid DS, Bellini WJ, Schmidt C, Gilden D, Cohrs RJ.
    J Neurol Sci; 2011 May 15; 304(1-2):22-4. PubMed ID: 21419427
    [Abstract] [Full Text] [Related]

  • 18. Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation.
    Kurapati S, Sadaoka T, Rajbhandari L, Jagdish B, Shukla P, Ali MA, Kim YJ, Lee G, Cohen JI, Venkatesan A.
    J Virol; 2017 Sep 01; 91(17):. PubMed ID: 28637759
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.